23 件 ・ 関連度順
概要と使いどころ
Accelerate LLM inference using speculative decoding, Medusa multiple heads, and lookahead decoding techniques. Use when optimizing inference speed (1.5-3.6× speedup), reducing latency for real-time applications, or deploying models with limited compute. Covers draft models, tree-based attention, Jacobi iteration, parallel token generation, and production deployment strategies.
日本語の概要は準備中です。原文の説明を表示しています。
Accelerate LLM inference using speculative decoding, Medusa multiple heads, and lookahead decoding techniques. Use when optimizing inference speed (1.5-3.6× speedup), reducing latency for real-time applications, or deploying models with limited compute. Covers draft models, tree-based attention, Jacobi iteration, parallel token generation, and production deployment strategies.
日本語の概要は準備中です。原文の説明を表示しています。
Full patent drafting pipeline from invention description to jurisdiction-formatted filing documents. Supports CN (CNIPA), US (USPTO), EP (EPO). Supports invention patents and utility models. Use when user says "写专利", "patent pipeline", "专利申请", "draft patent", "写权利要求书", or wants to draft a complete patent application.
日本語の概要は準備中です。原文の説明を表示しています。
Generates draft requirements from Simulink models. Use when drafting or updating requirement artifacts from a model. Prefers Requirements Toolbox (.slreqx) when available; falls back to structured YAML.
日本語の概要は準備中です。原文の説明を表示しています。
Edit mathematically, empirically, or technically dense papers for readers outside the author’s specialty, including empirical legal scholarship, law-and-economics models, and legal-technology research. Clarifies terminology, antecedents, study design, and claim–statistic relationships while checking equations, numbers, quotations, and citations against the source. Use to clarify exposition or de-jargonize a technical draft; not to rewrite briefs or doctrinal arguments. Produces an edited draft and audit memo. Full integrity checks and original-format rendering require suitable extraction, code execution, and document tools; otherwise provides proposed edits with verification limits disclosed.
日本語の概要は準備中です。原文の説明を表示しています。
Acelere a inferência de LLMs usando especulative decoding, múltiplas cabeças Medusa e técnicas de lookahead decoding. Use ao otimizar velocidade de inferência (aceleração de 1,5-3,6×), reduzir latência em aplicações em tempo real ou fazer deploy de modelos com recursos computacionais limitados. Cobre modelos draft, atenção em árvore, iteração de Jacobi, geração paralela de tokens e estratégias de deploy em produção.
日本語の概要は準備中です。原文の説明を表示しています。
Generate AI videos using ByteDance Seedance models via Volcengine Ark API. Supports text-to-video, image-to-video (first frame, first+last frame), multimodal reference (images+videos+audio), video editing, video extension, web search enhancement, audio generation, draft mode, offline inference, and continuous video chaining. Use when user wants to generate, create, edit, or extend AI videos from text prompts, images, videos, or audio.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Restructure any rough build, research, or legal-drafting request into an IRAC-shaped prompt — Issue, Rule, Analysis, Conclusion — optimized for a frontier model. It's the bar-exam framework, repurposed as prompt engineering. The skill leads with the issue and ends with the conclusion (where models weight attention most), forces you to name your constraints and non-goals, and specifies what "good" looks like before a single token is generated. Use it before any non-trivial build, or whenever a vague ask deserves a precise brief.
日本語の概要は準備中です。原文の説明を表示しています。
Routes any legal task to the right LLM, like OpenRouter but for legal work and grounded in benchmarks instead of brand loyalty. Built from mid-2026 legal evals (legalbenchmarks.ai, Vals AI × Stanford LegalBench across 124 models, Harvey's Legal Agent Benchmark, the Atticus Project's CUAD/MAUD/ACORD) plus translation evidence (WMT25, SwiLTra-Bench, ArabLegalEval). Covers five verticals: contract drafting, info extraction, legal research, contract review, and legal translation (including Arabic/MENA). Each asks up to four questions (cost, speed, accuracy/stakes, privacy/jurisdiction/language), then returns a primary model, a fallback, what to avoid, and what a human must verify. Core principle: capability is not controllability, so every route ends with a verification step. Not legal advice; a lawyer owns the output.
日本語の概要は準備中です。原文の説明を表示しています。
Works out which documents you have to hand over to the other side in a civil case in England & Wales, and builds the formal list. The part it gets right that trips people up is which disclosure regime applies — Practice Direction 57AD (the Disclosure Pilot, now permanent in the Business and Property Courts, with its Models A–E) or standard disclosure under CPR Part 31 everywhere else. It picks the regime, chooses a Model per issue, structures the Disclosure Review Document, and drafts the disclosure certificate for the party to sign personally. Built for litigation juniors, in-house counsel, and small teams without a precedent bank. Use when the user says 'disclosure list', 'PD 57AD', 'Model C', 'extended disclosure', 'List of Documents', 'N265', or needs to work out what must be disclosed.
日本語の概要は準備中です。原文の説明を表示しています。
Split a multi-call LM workflow by cognitive load, not by accuracy: let one strong model make the few reasoning decisions and a cheap model do the many mechanical executions (Aider architect+editor, DSPy optimizer-LM vs task-LM, vLLM speculative draft+target, LangGraph supervisor+worker are the same shape). Use when designing or cost-optimizing a pipeline that calls an LM many times, when deciding which steps need a strong reasoner vs a cheap executor, or when adding an escalation valve for when the cheap tier degrades. Search keywords: reduce LLM cost, cheaper model, lower token cost, model cascade, route to cheap model, strong model plus cheap model, LLM cost optimization.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
You are an expert in Contentful, the API-first content platform for enterprise teams. You help developers integrate Contentful's Content Delivery API (CDN-backed, read), Content Management API (write), and Content Preview API (draft content) into websites and apps — using typed content models, localization, rich text rendering, image transformations, and webhooks for build triggers.
日本語の概要は準備中です。原文の説明を表示しています。
Writes or reviews a pre-analysis plan before data collection — registry choice (OSF, AEA RCT Registry, AsPredicted, registered reports), PAP structure, models and decision rules locked in advance, analysis code run on simulated data, contingencies for attrition, failed manipulations, and exclusions, deviation records, and timeline. Operationalizes the pre-data-collection side of DA-RT. Use when the user asks to draft or audit a pre-registration or PAP, choose a registry, decide what to lock versus leave exploratory, or handle a later deviation. Hypotheses and estimands come from hypothesis-building, post-hoc reporting from methods-reporting.
日本語の概要は準備中です。原文の説明を表示しています。
Writes or reviews a pre-analysis plan before data collection: registry choice (OSF, AEA, AsPredicted, registered reports), locked models and decision rules, code run on simulated data, contingencies, and deviation records. Use when drafting or auditing a pre-registration or PAP, choosing a registry, or handling a deviation.
日本語の概要は準備中です。原文の説明を表示しています。
Write or rewrite prose so it sounds like a human wrote it — not a frontier model. Named in homage to Rabindranath Tagore, whose prose carried what frontier models reach for and miss: a point of view, specificity over abstraction, and restraint over puffery. Merges two complementary approaches: a 29-pattern catalog of AI tells (from humanizer) plus an 8-rule operating system with an 8-dimension scoring gate (extending stop-slop). Use when drafting, editing, or reviewing any prose: essays, posts, docs, reports, emails. Detects and removes inflated symbolism, promotional language, superficial -ing analyses, vague attributions, em dash overuse, rule of three, AI vocabulary, passive voice, negative parallelisms, filler phrases, inanimate-verb constructions, narrator-from-a-distance voice, and metronomic rhythm. Adds back the things AI writing usually lacks: point of view, stakes, specificity, restraint, varied rhythm, and trust in the reader.
日本語の概要は準備中です。原文の説明を表示しています。
Django Redis caching with django-cacheops. This skill should be used when implementing caching, adding cache invalidation, optimizing API performance, modifying models that affect cached data, or debugging cache-related issues in the Django backend.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Create, revise, and validate publication-ready academic paper figures and tables. Use for LaTeX tables, related-work comparison tables, result tables, notation/dataset/taxonomy tables, precise source-data-driven experiment plots from CSV/JSON/logs, generated conceptual figures such as system overviews/pipelines/architectures/threat models, captions, artifact specs, source-data traceability, and paper-ready PDF/SVG/PNG/LaTeX exports. Do not use for prose-only paper writing, self-review, reviewer response, rebuttal drafting, or external literature-management workflows.
日本語の概要は準備中です。原文の説明を表示しています。
Knowledge base from the NIST Framework for Cyber-Physical Systems (SP 1500-201/202/203, v1.0, 2017). Use for engineering and analyzing cyber-physical systems (CPS) and IoT: the CPS Framework's aspect × facet grid (nine aspects of concern examined through conceptualization, realization, and assurance facets), cross-property trustworthiness risk management (safety/security/privacy/reliability/resilience together), data interoperability (syntactical/semantic/contextual, canonical models, identifiers, provenance), the timing aspect (time-interval classes, time domains, time-aware networking) and secure/resilient time (GNSS jamming/spoofing, PTP/NTP attacks, holdover, the clock-error model and Allan/MTIE metrics), plus the use-case requirements method. Bridges IT and OT under a clock. Scope limits: a 2017 living/draft document, thin on post-2017 standards and on detailed control catalogs; it names but does not reproduce ISO/IEC/IEEE 42010 and 15288 process text or permission-licensed third-party figures.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。